These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. ABC: a novel algorithm to stratify decompensation risk in patients with compensated advanced chronic liver disease (CHESS2108): an international, multicenter cohort study. Liu C; Li J; Wong YJ; Xie Q; Hirooka M; Enomoto H; Kim TH; Hanafy AS; He R; Koizumi Y; Hiasa Y; Nishimura T; Iijima H; Jung YK; Yim HJ; Ma J; Zeng QL; Sarin SK; Qi X Hepatol Int; 2022 Oct; 16(5):1105-1115. PubMed ID: 35606627 [TBL] [Abstract][Full Text] [Related]
10. Validation of Baveno VII criteria for clinically significant portal hypertension by two-dimensional shear wave elastography. He R; Liu C; Grgurevic I; Guo Y; Xu H; Liu J; Liu Y; Wang X; Shi H; Madir A; Podrug K; Zhu Y; Hua Y; Wang K; Wen J; Su M; Zhang Q; Li J; Qi X Hepatol Int; 2024 Jun; 18(3):1020-1028. PubMed ID: 38740698 [TBL] [Abstract][Full Text] [Related]
11. Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma. Souhami A; Sartoris R; Rautou PE; Cauchy F; Bouattour M; Durand F; Giannelli V; Gigante E; Castera L; Valla D; Soubrane O; Vilgrain V; Ronot M JHEP Rep; 2020 Oct; 2(5):100147. PubMed ID: 32885156 [TBL] [Abstract][Full Text] [Related]
14. Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease-induced cirrhosis. Dallio M; Romeo M; Vaia P; Auletta S; Mammone S; Cipullo M; Sapio L; Ragone A; Niosi M; Naviglio S; Federico A World J Gastroenterol; 2024 Feb; 30(7):685-704. PubMed ID: 38515952 [TBL] [Abstract][Full Text] [Related]
15. Assessment of the Performance of Non-invasive Criteria for the Evaluation of Clinically Significant Portal Hypertension in Patients with Compensated Advanced Chronic Liver Disease. Jindal A; Agarwal S; Sharma S; Kumar M; Saraya A; Sarin SK Dig Dis Sci; 2023 May; 68(5):2149-2157. PubMed ID: 36562888 [TBL] [Abstract][Full Text] [Related]
16. A Combined Baveno VII and Spleen Stiffness Algorithm to Improve the Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease. Dajti E; Ravaioli F; Marasco G; Alemanni LV; Colecchia L; Ferrarese A; Cusumano C; Gemini S; Vestito A; Renzulli M; Golfieri R; Festi D; Colecchia A Am J Gastroenterol; 2022 Nov; 117(11):1825-1833. PubMed ID: 35973171 [TBL] [Abstract][Full Text] [Related]
18. Validation of the New Diagnostic Criteria for Clinically Significant Portal Hypertension by Platelets and Elastography. Podrug K; Trkulja V; Zelenika M; Bokun T; Madir A; Kanizaj TF; O'Beirne J; Grgurevic I Dig Dis Sci; 2022 Jul; 67(7):3327-3332. PubMed ID: 34739624 [TBL] [Abstract][Full Text] [Related]
19. Validation of non-invasive diagnosis of CSPH in patients with compensated advanced chronic liver disease according to Baveno VII. Song BG; Goh MJ; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Paik SW; Sinn DH Liver Int; 2023 Sep; 43(9):1966-1974. PubMed ID: 37288716 [TBL] [Abstract][Full Text] [Related]